series-c-plus
Stage
2012
Founded
4
Investors
About
Immunic Therapeutics is a clinical-stage biotechnology company developing orally administered small-molecule therapies for chronic inflammatory, autoimmune and neurologic diseases, with programs targeting multiple sclerosis, celiac disease and other immune-mediated conditions.
Explore Immunic Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.